Aperion Biologics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Distribution Services » Medical Distributors
MCKMcKesson Corp.
CAHCardinal Health, Inc.
ABCAmerisourceBergen Corp.
HSICHenry Schein, Inc.
PDCOPatterson Cos., Inc.
OMIOwens & Minor, Inc.
MYOMyomo, Inc.

Company Profile

Aperion Biologics, Inc. is a clinical-stage medical device company addressing the need for alternatives to human-based grafts with animal-based tissue technology. Aperion Biologics, Inc. developed and patented a technique to make animal-tissues usable for human applications without causing rejection. The core platform technology is an enzymatic stripping of the key carbohydrate antigens followed by a unique conversion process that both “humanizes” and sterilizes the tissues without affecting their biomechanical or biological properties. This tissue scaffold provides mechanical stability and function while being biologically integrated and remodeled. Aperion’s Z-Process® of humanizing and sterilizing tissue can be applicable to a variety of tissues from orthopedic ligaments, bone, and meniscus to valves and vessels to soft tissue grafts for augmentation and repair. The company’s lead product for knee ligament reconstruction, the Z-Lig® ACLR Device, is currently under clinical investigation and not commercially approved for sale in the United States, European Union or other markets.